Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 59651-083

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 59651-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Time To 12-week Confirmed Progression Of Disability (study 1) (Dimethyl Fig1)

Figure 1: Time To 12-week Confirmed Progression Of Disability (study 1) (Dimethyl Fig1)
This is a graph that shows the percentage of subjects with confirmed progression of disability over a 96-week study period. The study included two groups: a placebo group (n=408) and a group receiving 240mg of dimethyl fumarate delayed-release capsules twice a day (n=409). The percentage of subjects with confirmed progression of disability was 27.1% at baseline and 16.4% at the end of the study.*
FDA Label Image

Dimethyl-fig2 (Dimethyl Fig2)

Dimethyl-fig2 (Dimethyl Fig2)
This is a prescription drug with NDC code 59651-083-14 commonly known as Dimethyl Fumarate Delayed-Release Capsules. Each capsule has 120mg of Geometyfumarte and is distributed by Aurobindo Pharma USA, Inc located in East Windsor, NJ. It is suggested to take one capsule by mouth per day. The package should be referred to for dosage and administration instructions. The drug is made in India. Store it in its original container between 20 to 25 degrees Celsius and protect it from light.*
FDA Label Image

Dimethyl-fig3 (Dimethyl Fig3)

Dimethyl-fig3 (Dimethyl Fig3)
This is a description of a medication named Reonly which is available in 240mg delayed-release capsules. The manufacturer of the drug is Aurobindo Pharma USA. The usual dosage recommendation is one capsule to be taken orally. The medication is intended for controlled autoimmune disorders and distributed in original packaging. The NDC code for the medication is 59651-084-60.*
FDA Label Image

Dimethyl-str (Dimethyl Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.